Ensayos clínicos de Obesidad en Kansas
35 estudios sobre Obesidad buscan participantes en Kansas.
Ciudades en Kansas
Texto oficial del estudio (inglés)
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- AMR Clinical - Wichita, Wichita
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07685808A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- Cotton O'Neil Diabetes & Endocrinology, Topeka
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07589608A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Cotton O'Neil Diabetes & Endocrinology, Topeka
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07392190A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
- AMR Clinical, Newton
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07153471A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Lenexa
- Research Site, Newton
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07784270Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- AMR Clinical, Newton
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07353931A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Cotton O'Neil Clinical Research Center, Topeka
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07321886Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Cotton-ONeil Diabetes and Endocrinology Center, Topeka
ReclutandoFase 3
Edades de 45 a 99 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07037433A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Kansas City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Kansas City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07743450Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- University of Kansas Medical Center, Kansas City
- Johnson County Clintrials, Lenexa
- Kansas Nephrology Research Institute LLC, Wichita
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 16 sept 2026 · NCT07037459A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Wichita
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 18 a 79 · Todos los sexos · Actualizado el 11 sept 2026 · NCT07654374A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Cotton O'Neil Diabetes & Endocrinology, Topeka
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 8 sept 2026 · NCT06143956A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
- ICON Early Phase Services, LLC, Lenexa
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 18 a 55 · Todos los sexos · Actualizado el 4 sept 2026 · NCT07767175Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Alliance for Multispecialty Research Newton, Newton
- Alliance for Multispecialty Research LLC, Wichita
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 3 sept 2026 · NCT07684144Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Newton
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Alliance for Multispecialty Research Newton, Newton
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 3 sept 2026 · NCT07684235Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
- Kailera Clinical Site, Newton
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 sept 2026 · NCT07284979A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Cotton O'Neil Clinical Research Center, Topeka
ReclutandoFase 3
Edades de 8 a 18 · Todos los sexos · Actualizado el 31 ago 2026 · NCT07253285Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Children's Mercy Hospital, Kansas City
ReclutandoFase 2
Edades de 7 a 25 · Todos los sexos · Actualizado el 19 ago 2026 · NCT05082519A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- West Houston Area Clinical Trial Consultants, Wichita
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT07567001Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
- University of Kansas Medical Center, Kansas City
Reclutando
Edades de 18 a 35 · Todos los sexos · Actualizado el 11 ago 2026 · NCT06961591Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Wichita
ReclutandoFase 3
Edades de 18 a 79 · Todos los sexos · Actualizado el 10 ago 2026 · NCT07654361Gestational Response, Outcomes, and Weight After GLP-1 Use
- University of Kansas Medical Center, Kansas City
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 a 45 · Mujeres · Actualizado el 4 ago 2026 · NCT07743567A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
- ICON Early Phase Services, LLC, Lenexa
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 18 a 55 · Todos los sexos · Actualizado el 29 jul 2026 · NCT07437079Changes in Body Composition Including Muscle With Anti-Obesity Medications, Both With and Without Exercise
- University of Kansas Medical Center, Kansas City
Reclutando
Edades de 18 a 64 · Todos los sexos · Actualizado el 15 jul 2026 · NCT07698145Feasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Transplant Recipients (HEAL)
- University of Kansas Medical Center, Kansas City
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 jul 2026 · NCT06640179Muscle and Movement With Anti-Obesity Medications
- University of Kansas Medical Center, Kansas City
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 may 2026 · NCT06645470A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight
- Altasciences Clinical Kansas, Inc., Overland Park
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 18 a 64 · Mujeres · Actualizado el 24 abr 2026 · NCT07525791A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
- Altasciences Clinical Kansas, Inc., Overland Park
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 21 abr 2026 · NCT07395687Brain Outcomes With Lifestyle Change in Down Syndrome
- University of Kansas Medical Center, Kansas City
Reclutando
Edades de 18 a 64 · Todos los sexos · Actualizado el 11 mar 2026 · NCT05985486Comparision of Aerobic Exercise to Aerobic Plus Yoga Exercise for Weight Loss in Adults With Overweight or Obesity.
- University of Kansas Medical Center, Kansas City
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 ene 2026 · NCT06636773Mitigating the Pro-inflammatory Phenotype of Obesity
- University of Kansas Medical Center, Kansas City
ReclutandoFase 1
Edades de 18 a 79 · Todos los sexos · Actualizado el 5 jun 2025 · NCT04934228Transduction of Sympathetic Neural Activity in Human Obesity Without Hypertension
- University of Kansas Medical Center, Kansas City
ReclutandoEstudio observacional
Edades de 18 a 79 · Todos los sexos · Actualizado el 3 oct 2024 · NCT06626113International Weight Control Registry
- University of Kansas Medical Center, Kansas City
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 sept 2024 · NCT04907396De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.